| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $652K | +104.4% |
| SG&A Expense | $1.2M | +171.8% |
| Operating Income | -$1.9M | -144.1% |
| Interest Expense | $59K | +353.8% |
| Income Tax | -$70K | — |
| Net Income | -$387K | +54.0% |
| EPS (Diluted) | -$0.04 | +55.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $197K | +885.0% |
| Current Assets | $255K | -1.5% |
| Total Assets | $9.1M | +2627.4% |
| Current Liabilities | $2.3M | +148.7% |
| Total Liabilities | $3.9M | +313.9% |
| Stockholders' Equity | $1.6M | +359.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -72.6% |
| Investing Cash Flow | $2K | — |
| Financing Cash Flow | $934K | +20.2% |